HSA
CVS icon

HBK Sorce Advisory’s CVS Health CVS Stock Holding History

HBK Sorce Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Sell
22,836
-749
-3% -$66.9K 0.04% 148
2026
Q1 		$2.14M Sell
23,585
-1,363
-5% -$105K 0.04% 145
2025
Q4 		$1.95M Sell
24,948
-1,718
-6% -$135K 0.04% 156
2025
Q3 		$2.15M Sell
26,666
-660
-2% -$45.2K 0.05% 138
2025
Q2 		$1.88M Sell
27,326
-455
-2% -$29.8K 0.05% 140
2025
Q1 		$1.88M Sell
27,781
-552
-2% -$33K 0.06% 139
2024
Q4 		$1.27M Sell
28,333
-5,531
-16% -$310K 0.04% 188
2024
Q3 		$2.13M Sell
33,864
-2,666
-7% -$156K 0.06% 133
2024
Q2 		$2.16M Sell
36,530
-12,675
-26% -$793K 0.08% 126
2024
Q1 		$3.92M Buy
49,205
+671
+1% +$51.3K 0.14% 75
2023
Q4 		$3.83M Buy
48,534
+2,347
+5% +$167K 0.15% 69
2023
Q3 		$3.22M Buy
46,187
+1,718
+4% +$122K 0.14% 83
2023
Q2 		$3.07M Sell
44,469
-5,805
-12% -$413K 0.13% 87
2023
Q1 		$3.74M Sell
50,274
-62,514
-55% -$5.24M 0.17% 79
2022
Q4 		$10.5M Buy
112,788
+49,167
+77% +$4.74M 0.28% 49
2022
Q3 		$6.07M Buy
63,621
+8,206
+15% +$812K 0.41% 41
2022
Q2 		$5.13M Sell
55,415
-4,335
-7% -$423K 0.38% 36
2022
Q1 		$6.05M Sell
59,750
-221
-0.4% -$23.2K 0.33% 46
2021
Q4 		$6.19M Buy
59,971
+863
+1% +$79.7K 0.31% 46
2021
Q3 		$5.02M Buy
59,108
+5,787
+11% +$485K 0.28% 50
2021
Q2 		$4.45M Sell
53,321
-102
-0.2% -$8.35K 0.25% 58
2021
Q1 		$4.02M Buy
53,423
+1,791
+3% +$130K 0.24% 60
2020
Q4 		$3.53M Buy
51,632
+13,818
+37% +$899K 0.22% 65
2020
Q3 		$2.21M Buy
37,814
+1,963
+5% +$122K 0.16% 95
2020
Q2 		$2.33M Buy
35,851
+4,258
+13% +$268K 0.17% 88
2020
Q1 		$1.87M Buy
31,593
+3,717
+13% +$248K 0.18% 87
2019
Q4 		$2.07M Buy
27,876
+8,399
+43% +$590K 0.18% 97
2019
Q3 		$1.23M Buy
19,477
+946
+5% +$56.1K 0.12% 131
2019
Q2 		$1.01M Sell
18,531
-289
-2% -$15.6K 0.1% 154
2019
Q1 		$1.01M Buy
18,820
+1,133
+6% +$69.9K 0.1% 152
2018
Q4 		$1.16M Buy
17,687
+792
+5% +$59.1K 0.13% 129
2018
Q3 		$1.33M Buy
16,895
+7
+0% +$500 0.15% 105
2018
Q2 		$1.09M Buy
16,888
+2,250
+15% +$148K 0.13% 119
2018
Q1 		$911K Buy
14,638
+1,291
+10% +$92.6K 0.11% 135
2017
Q4 		$968K Buy
13,347
+6,159
+86% +$448K 0.11% 132
2017
Q3 		$585K Sell
7,188
-64
-0.9% -$5.06K 0.09% 157
2017
Q2 		$584K Buy
+7,252
New +$573K 0.09% 154
2017
Q1 		– Sell
-9,330
Closed -$745K – 333
2016
Q4 		$736K Sell
9,330
-1,725
-16% -$140K 0.13% 118
2016
Q3 		$984K Buy
11,055
+1,401
+15% +$132K 0.2% 81
2016
Q2 		$924K Buy
9,654
+399
+4% +$39.8K 0.2% 84
2016
Q1 		$960K Buy
9,255
+1,301
+16% +$127K 0.23% 73
2015
Q4 		$778K Buy
7,954
+621
+8% +$60.8K 0.2% 76
2015
Q3 		$707K Buy
7,333
+503
+7% +$52.9K 0.23% 64
2015
Q2 		$716K Buy
6,830
+359
+6% +$36.7K 0.24% 63
2015
Q1 		$668K Buy
6,471
+821
+15% +$83.1K 0.23% 68
2014
Q4 		$544K Sell
5,650
-353
-6% -$31.1K 0.19% 90
2014
Q3 		$478K Sell
6,003
-305
-5% -$24K 0.17% 84
2014
Q2 		$475K Buy
6,308
+26
+0.4% +$1.97K 0.16% 87
2014
Q1 		$470K Sell
6,282
-225
-3% -$15.9K 0.17% 84
2013
Q4 		$466K Sell
6,507
-1,200
-16% -$77.1K 0.17% 85
2013
Q3 		$437K Sell
7,707
-9,207
-54% -$549K 0.18% 83
2013
Q2 		$968K Buy
+16,914
New +$980K 0.21% 75

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

HBK Sorce Advisory's CVS Position: Q2 2026 in Review

HBK Sorce Advisory reduced its CVS Health (CVS) stake by 3.2% in Q2 2026, selling an estimated $66.9K and leaving 22,836 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #148.

HBK Sorce Advisory first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.5M in Q4 2022. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • HBK Sorce Advisory held 22,836 shares of CVS Health worth $2.26M as of Q2 2026.
  • HBK Sorce Advisory sold 749 CVS Health shares in Q2 2026, an estimated $66.9K.
  • CVS Health made up 0.04% of HBK Sorce Advisory's portfolio in Q2 2026, its #148 holding.
  • HBK Sorce Advisory first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • HBK Sorce Advisory's CVS Health position peaked at $10.5M in Q4 2022.
  • 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.